Remote Pathology Research Scientist (Contract)

Rancho BioSciences; España; À distance; EUR 61 328 - 96 373; Temps partiel

Résumé du poste

Rancho BioSciences is seeking an experienced Pathology Research Scientist to join on a part-time, contractor basis. The role focuses on biomarker discovery, diagnostic development, and computational pathology initiatives across translational research to clinical development.

The position requires deep expertise in surgical and digital pathology, collaboration with biomarker and data science teams, and the ability to ensure scientific rigor and regulatory-appropriate practices across drug

Qualifications

• MD/DO, MBBS, or equivalent with board certification/eligibility in AP or AP/CP.
• Advanced pathology training or subspecialty is preferred.
• Experience in clinical trials, translational research, or drug development is preferred.

Responsabilités

• Serve as a pathology SME for biomarker and diagnostic programs including companion diagnostics and digital pathology.
• Review literature and synthesize primary data to guide model design and interpretation.
• Support ML/AI initiatives by translating pathology knowledge into guidance for model development and validation.
• Define disease- and indication-specific annotation guidelines for tissue compartments and morphological features.
• Review digital slide annotations and provide quality control and validation documentation.

Connaissances

Pathology expertise

Cross-functional collaboration

Analytical thinking

Scientific writing

Formation

MD/DO or equivalent

Advanced degree (MS/MPH/PhD) a plus

Outils

Digital pathology platforms

AI-enabled workflows

Description du poste

Rancho BioSciences is seeking an experienced Pathology Research Scientist to join on a part-time, contractor basis. The role focuses on biomarker discovery, diagnostic development, and computational pathology initiatives across translational research to clinical development.

The position requires deep expertise in surgical and digital pathology, collaboration with biomarker and data science teams, and the ability to ensure scientific rigor and regulatory-appropriate practices across drug